Lotus Pharmaceuticals announces patent pending Gliclazide-Controlled Release Tablets.: An article from: BIOTECH Patent News

This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on August 1, 2009. The length of the article is 316 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Lotus Pharmaceuticals announces patent pending Gliclazide-Controlled Release Tablets.
Author: Unavailable
Publication:BIOTECH Patent News (Newsletter)
Date: August 1, 2009
Publisher: Biotech Patent News
Volume: 23 Issue: 8 Page: NA

Distributed by Gale, a part of Cengage Learning